Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|1|111-128

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.1, 2006-01, pp. : 111-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignancies of the head and neck: the role for molecular targeted agents

By Agulnik Mark  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite

Novel Targets for Antiinflammatory and Antiarthritic Agents

By  

Current Pharmaceutical Design, Vol. 12, Iss. 19, 2006-07 ,pp. : 2437-2454

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 978-993

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Epigenome in Hematopoietic Malignancies

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 242-252

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Integrin-Specific Targets for Anti-Platelet Therapies

By  

Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. : 1603-1609

Bentham Science Publishers

Access to resources Recommend Favorite